REHOVOT, Israel, March 28, 2025 (GLOBE NEWSWIRE) -- Purple Biotech ... announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune ...